GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Caliway Biopharmaceuticals Co 6919.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

70.40

+10.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 38.0m

FY2019FY2025

Net income

−TWD 351.4m

FY2019FY2025

Free cash flow

−TWD 443.0m

FY2019FY2025

Shareholders' equity

TWD 299.9m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueTWD 38.0mTWD 44.4mTWD 38.9mTWD 12.8mTWD 12.3mTWD 10.3mTWD 18.6m
Research and developmentTWD 649.5mTWD 649.0mTWD 503.4mTWD 295.2mTWD 180.4mTWD 88.9mTWD 109.0m
Operating income−TWD 706.1m−TWD 716.0m−TWD 512.8m−TWD 319.8m−TWD 230.4m−TWD 105.5m−TWD 122.0m
Net income−TWD 351.4m−TWD 587.9m−TWD 487.9m−TWD 286.3m−TWD 224.0m−TWD 98.4m−TWD 121.7m
Diluted earnings per share-0.23-0.38-0.39-0.23-0.23-0.13-0.17

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsTWD 301.9mTWD 9.77bnTWD 3.83bnTWD 1.23bnTWD 712.0mTWD 226.8mTWD 170.2m
Cash and short-term investmentsTWD 154.9mTWD 9.67bnTWD 3.71bnTWD 1.11bnTWD 594.1mTWD 93.5mTWD 21.7m
Total liabilitiesTWD 2.0mTWD 73.7mTWD 85.6mTWD 68.8mTWD 68.2mTWD 180.3mTWD 179.5m
DebtTWD 95,531TWD 11.9mTWD 20.5mTWD 28.7mTWD 36.8mTWD 130.8mTWD 155.5m
Shareholders' equityTWD 299.9mTWD 9.70bnTWD 3.74bnTWD 1.16bnTWD 643.8mTWD 46.6m−TWD 9.3m
Shares outstanding1,549m1,537m1,263m1,223m978m745m699m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−TWD 425.9m−TWD 522.3m−TWD 423.9m−TWD 242.8m−TWD 110.5m−TWD 47.2m−TWD 106.4m
Capital spending−TWD 17.1m−TWD 11.1m−TWD 9.7m−TWD 14.2m−TWD 14.9m−TWD 2.3m−TWD 13.2m
Free cash flow−TWD 443.0m−TWD 533.4m−TWD 433.6m−TWD 256.9m−TWD 125.4m−TWD 49.5m−TWD 119.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 3.6mTWD 1,999TWD 12.4mTWD 13.4mTWD 12.2m−TWD 43,713TWD 9.3mTWD 23.3m
Operating income−TWD 263.1m−TWD 245.8m−TWD 120.5m−TWD 201.3m−TWD 157.6m−TWD 227.5m−TWD 128.3m−TWD 153.1m
Net income−TWD 222.5m−TWD 107.8mTWD 80.1m−TWD 7.7m−TWD 247.5m−TWD 175.6m−TWD 56.0m−TWD 4.0m
Diluted earnings per share-0.14-0.070.05-0.00-0.16-0.11-0.04-0.00
Cash from operations−TWD 129.0m−TWD 22.0m−TWD 60.0m−TWD 68.0m−TWD 178.0m−TWD 118.0m−TWD 42.0m−TWD 119.0m
Capital spending−TWD 5.0m−TWD 4.0m−TWD 3.0m−TWD 6.0m−TWD 3.0m−TWD 3.0m—−TWD 2.0m
Free cash flow−TWD 134.0m−TWD 26.0m−TWD 63.0m−TWD 74.0m−TWD 181.0m−TWD 121.0m—−TWD 121.0m
Total assetsTWD 9.43bnTWD 9.54bnTWD 301.9mTWD 309.7mTWD 9.50bnTWD 9.66bnTWD 9.77bnTWD 9.80bn
Cash and short-term investmentsTWD 4.05bnTWD 4.89bnTWD 154.9mTWD 213.4mTWD 9.40bnTWD 9.55bnTWD 9.67bnTWD 9.69bn
DebtTWD 9.6mTWD 750,970TWD 95,531TWD 171,415TWD 7.5mTWD 8.9mTWD 8.9mTWD 8.8m
Shareholders' equityTWD 9.21bnTWD 9.36bnTWD 299.9mTWD 307.1mTWD 9.40bnTWD 9.56bnTWD 9.70bnTWD 9.73bn

Financial ratios

Data as of 4 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-1859.3%-1614.0%-1318.9%-2493.2%-1869.9%-1020.3%
Net margin-925.2%-1325.2%-1254.6%-2232.1%-1817.8%-951.6%
Return on equity-117.2%-6.1%-13.0%-24.6%-34.8%-211.4%
Return on assets-116.4%-6.0%-12.7%-23.2%-31.5%-43.4%
Free cash flow yield-0.3%-0.4%-0.4%-0.2%-0.1%—
Revenue growth-14.4%14.1%203.1%4.1%19.2%-44.5%
Earnings growth-40.2%20.5%70.4%27.8%127.7%-19.2%
Current ratio109.71x184.02x50.81x23.41x15.26x1.72x
Debt to equity0.00x0.00x0.00x0.01x0.02x0.32x
Equity ratio99.3%99.2%97.8%94.4%90.4%20.5%
Interest coverage-4534.35x-2160.23x-1031.09x-478.49x-79.38x—
R&D as a share of sales1710.3%1463.1%1294.5%2301.2%1463.8%859.7%
Buybacks as a share of market value-0.8%-21.7%-3.2%-25.1%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue43.6%29.7%—
Operating income30.2%46.3%—
Net income7.1%29.0%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-1727.1%-1682.0%-1653.1%—
Net margin-1140.7%-1278.2%-1299.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022
Price to earnings-683.2-160.8-49.5-26.2

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-for-1 split · 21 Jul 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.